114 related articles for article (PubMed ID: 8967025)
1. [Cathepsin B-like substance in the monitoring of chemically induced primary cholangiocarcinoma in swine].
Dufek V; Petrtýl J; Klener P
Vnitr Lek; 1996 Aug; 42(8):551-4. PubMed ID: 8967025
[TBL] [Abstract][Full Text] [Related]
2. Biliary carcinoembryonic antigen levels are a marker for cholangiocarcinoma.
Nakeeb A; Lipsett PA; Lillemoe KD; Fox-Talbot MK; Coleman J; Cameron JL; Pitt HA
Am J Surg; 1996 Jan; 171(1):147-52; discussion 152-3. PubMed ID: 8554130
[TBL] [Abstract][Full Text] [Related]
3. Proteomic profiling of cholangiocarcinoma: diagnostic potential of SELDI-TOF MS in malignant bile duct stricture.
Scarlett CJ; Saxby AJ; Nielsen A; Bell C; Samra JS; Hugh T; Baxter RC; Smith RC
Hepatology; 2006 Sep; 44(3):658-66. PubMed ID: 16941699
[TBL] [Abstract][Full Text] [Related]
4. Primary sclerosing cholangitis: patients with a rising alkaline phosphatase at annual follow-up.
Charatcharoenwitthaya P; Lindor KD
Clin Gastroenterol Hepatol; 2007 Jan; 5(1):32-6. PubMed ID: 17234554
[No Abstract] [Full Text] [Related]
5. [Immunohistochemical analysis for cholangiocarcinoma].
Nakagoe T; Matsuo T; Kondoh M; Yamaguchi H
Nihon Rinsho; 2006 Jan; 64 Suppl 1():370-4. PubMed ID: 16457285
[No Abstract] [Full Text] [Related]
6. [Tumor markers in the diagnosis of tumors in the subhepatic area].
Dufek V; Petrtýl J; Klener P; Chmel J
Vnitr Lek; 1994 Jun; 40(6):350-3. PubMed ID: 8073643
[TBL] [Abstract][Full Text] [Related]
7. Enhanced detection of cholangiocarcinoma with serum trypsinogen-2 in patients with severe bile duct strictures.
Lempinen M; Isoniemi H; Mäkisalo H; Nordin A; Halme L; Arola J; Höckerstedt K; Stenman UH
J Hepatol; 2007 Nov; 47(5):677-83. PubMed ID: 17640760
[TBL] [Abstract][Full Text] [Related]
8. The value of biliary fibronectin for diagnosis of cholangiocarcinoma.
Chen CY; Lin XZ; Tsao HC; Shiesh SC
Hepatogastroenterology; 2003; 50(52):924-7. PubMed ID: 12845951
[TBL] [Abstract][Full Text] [Related]
9. Serum and bile markers for cholangiocarcinoma.
Nehls O; Gregor M; Klump B
Semin Liver Dis; 2004 May; 24(2):139-54. PubMed ID: 15192787
[TBL] [Abstract][Full Text] [Related]
10. The assessment of biliary CA 125, CA 19-9 and CEA in diagnosing cholangiocarcinoma--the influence of sampling time and hepatolithiasis.
Chen CY; Shiesh SC; Tsao HC; Lin XZ
Hepatogastroenterology; 2002; 49(45):616-20. PubMed ID: 12063953
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of serum tumour M2-PK and CA19-9 detection in the diagnosis of cholangiocarcinoma.
Li YG; Zhang N
Dig Liver Dis; 2009 Aug; 41(8):605-8. PubMed ID: 19168405
[TBL] [Abstract][Full Text] [Related]
12. Serum cytokeratin 19 fragment (CYFRA21-1) as a prognostic factor in intrahepatic cholangiocarcinoma.
Uenishi T; Yamazaki O; Tanaka H; Takemura S; Yamamoto T; Tanaka S; Nishiguchi S; Kubo S
Ann Surg Oncol; 2008 Feb; 15(2):583-9. PubMed ID: 17955299
[TBL] [Abstract][Full Text] [Related]
13. Accuracy of the preoperative determination of tumor markers in the differentiation of liver mass lesions in surgical patients.
Torzilli G; Makuuchi M; Ferrero A; Takayama T; Hui AM; Abe H; Inoue K; Nakahara K
Hepatogastroenterology; 2002; 49(45):740-5. PubMed ID: 12063982
[TBL] [Abstract][Full Text] [Related]
14. Early detection and treatment of cholangiocarcinoma.
Gores GJ
Liver Transpl; 2000 Nov; 6(6 Suppl 2):S30-4. PubMed ID: 11084082
[TBL] [Abstract][Full Text] [Related]
15. The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis.
Patel AH; Harnois DM; Klee GG; LaRusso NF; Gores GJ
Am J Gastroenterol; 2000 Jan; 95(1):204-7. PubMed ID: 10638584
[TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance imaging of cholangiocarcinoma.
Manfredi R; Barbaro B; Masselli G; Vecchioli A; Marano P
Semin Liver Dis; 2004 May; 24(2):155-64. PubMed ID: 15192788
[TBL] [Abstract][Full Text] [Related]
17. Carcinoembryonic antigen and blood group-related carbohydrate antigens in glycoproteins in human bile in hepatolithiasis. Japanese Study Group of Hepatolithiasis.
Sasaki M; Morita T; Hoso M; Nakanuma Y; Tanimura H
Hepatology; 1996 Feb; 23(2):258-63. PubMed ID: 8591850
[TBL] [Abstract][Full Text] [Related]
18. Detection of cholangiocarcinoma with magnetic resonance spectroscopy of bile in patients with and without primary sclerosing cholangitis.
Albiin N; Smith IC; Arnelo U; Lindberg B; Bergquist A; Dolenko B; Bryksina N; Bezabeh T
Acta Radiol; 2008 Oct; 49(8):855-62. PubMed ID: 18608012
[TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance spectroscopy of bile in the detection of cholangiocarcinoma.
Ijare OB; Bezabeh T; Albiin N; Smith IC
J Hepatol; 2011 Feb; 54(2):398-9; author reply 399-400. PubMed ID: 21112110
[No Abstract] [Full Text] [Related]
20. Canalicular immunostaining of aminopeptidase N (CD13) as a diagnostic marker for hepatocellular carcinoma.
Röcken C; Licht J; Roessner A; Carl-McGrath S
J Clin Pathol; 2005 Oct; 58(10):1069-75. PubMed ID: 16189153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
